Actively Recruiting
Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery
Led by Elios Vision, Inc. · Updated on 2025-11-26
194
Participants Needed
16
Research Sites
225 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively.
CONDITIONS
Official Title
Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects
- 40 years old or older
- Diagnosis of mild to moderate primary open-angle glaucoma, pseudoexfoliation glaucoma or pigmentary glaucoma
- Visually significant cataract eligible for phacoemulsification
You will not qualify if you...
- All forms of angle closure glaucoma
- Secondary glaucoma including traumatic, neovascular, uveitic, lens-induced, steroid-induced, angle-recession, glaucoma associated with vascular disorders, and glaucoma associated with increased episcleral venous pressure
- Congenital or developmental glaucoma
- Prior incisional glaucoma surgery, intraocular surgery or ocular laser treatment except selective laser trabeculoplasty within 6 months before screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 16 locations
1
ELIOS Clinical Site
Leuven, Belgium
Actively Recruiting
2
Elios Clinical Site
Avranches, France
Actively Recruiting
3
ELIOS Clinical Site
Bordeaux, France
Actively Recruiting
4
ELIOS clinical site
Paris, France
Actively Recruiting
5
ELIOS Clinical Site
Bochum, Germany
Actively Recruiting
6
Elios clinical site
Bonn, Germany
Actively Recruiting
7
ELIOS clinical site
Heidelberg, Germany
Actively Recruiting
8
ELIOS Clinical Site
Maastricht, Netherlands
Actively Recruiting
9
ELIOS clinical site
Barcelona, Spain
Actively Recruiting
10
ELIOS Clincal Site
Madrid, Spain
Actively Recruiting
11
ELIOS Clinical site
Madrid, Spain
Actively Recruiting
12
ELIOS Clinical Site
East Grinstead, United Kingdom
Actively Recruiting
13
ELIOS Clinical Site
Edinburgh, United Kingdom
Actively Recruiting
14
ELIOS Clinical Site
Guildford, United Kingdom
Actively Recruiting
15
ELIOS clinical site
London, United Kingdom
Actively Recruiting
16
ELIOS Clinical Site
Manchester, United Kingdom
Actively Recruiting
Research Team
C
Cameron Hudson
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here